Jpmorgan Chase & Co »

Iteos Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-12-31 $16M 2.1M 7.68
2024-09-30 $4.8M 467k 10.21
2024-06-30 $6.9M 462k 14.84
2024-03-31 $242k 18k 13.64
2023-12-31 $255k 23k 10.95
2023-09-30 $260k 24k 10.95
2023-06-30 $271k 20k 13.24
2023-03-31 $6.9M 496k 13.96
2022-12-31 $11M 584k 19.53
2022-06-30 $12M 559k 20.61
2022-03-31 $7.3M 227k 32.18
2021-12-31 $2.7M 59k 46.65
2021-03-31 $338k 9.9k 34.05
2020-12-31 $171k 5.0k 33.87
2020-09-30 $96k 4.0k 24.10